Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2026 - Issue 5

Why Artificial Intelligence–Enabled Medication Decision Support Becomes Useful, Ignored, or Routinely Overridden: A Realist Review of Workflow Conditions, Professional Trust, and Organizational Responses Download PDF


, , ,
  1. Department of Clinical Pharmacy and AI Decision Support, University of Bern, Bern, Switzerland.
  2. Department of Pharmacy Practice and Professional Trust, University of Dhaka, Dhaka, Bangladesh.
  3. Department of Pharmaceutical Care and Health Informatics, University of Amsterdam, Amsterdam, Netherlands.
  4. Department of Clinical Pharmacy and Organizational Behavior, Cairo University, Cairo, Egypt.
Abstract

Artificial intelligence (AI)–enabled medication decision support can improve the identification and prioritization of prescribing risks, yet recommendations may be used selectively, ignored, or routinely overridden. These responses have different clinical meanings that cannot be determined from acceptance rates alone. This realist review examines how workflow conditions, professional trust, and organizational responses interact to shape medication decision-support use. Peer-reviewed literature published between 2018 and 2026 was identified through targeted scholarly searching and mapped against an initial programme theory. Context–mechanism–outcome reasoning was used to distinguish system characteristics, clinician interpretation, and observable actions. The evidence indicates that algorithmic performance, perceived relevance, interruption burden, professional accountability, and institutional implementation practices are distinct considerations in understanding medication-support behavior. It also identifies important differences between medication-alert studies, simulated human–AI decisions, and real-world implementation evaluations. However, complete record-level screening denominators and included-evidence-unit linkage were not recoverable from the search record, limiting final selection-flow reporting and confidence in a comprehensive synthesis. The explanatory account therefore remains conditional: useful uptake requires a combination of clinically relevant advice, workable opportunities for interpretation, and organizational arrangements that preserve professional judgment.  Override and non-use require contextual evaluation because they may represent appropriate clinical reasoning, adaptation to workflow constraints, or failure of implementation.

Cite this article
Vancouver
Berger T, Rahman N, Meyer L, Khalil R. Why Artificial Intelligence–Enabled Medication Decision Support Becomes Useful, Ignored, or Routinely Overridden: A Realist Review of Workflow Conditions, Professional Trust, and Organizational Responses. Pharmacophore. 2026;17(5):63-73. https://doi.org/10.51847/H5FK3a0ddQ
APA
Berger, T., Rahman, N., Meyer, L., & Khalil, R. (2026). Why Artificial Intelligence–Enabled Medication Decision Support Becomes Useful, Ignored, or Routinely Overridden: A Realist Review of Workflow Conditions, Professional Trust, and Organizational Responses. Pharmacophore, 17(5), 63-73. https://doi.org/10.51847/H5FK3a0ddQ

Related articles:
Most viewed articles:
QR code:

Short Link:
Views: 155

Downloads: 23
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2026 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.